Endocrinology & Metabolism
CagriSema Plus Basal Insulin in Type 2 Diabetes: HbA1c, Weight Loss, and Hypoglycemia Findings From REIMAGINE 3
REIMAGINE 3 found glycemic and weight benefits when cagrilintide-semaglutide was added to basal insulin in adults with type 2 diabetes. Hypoglycemia remains central to interpreting treatment escalation.
Dr. Abu Bakar · September 7, 2026 · 6 min